ACTELION PHARMACEUTICALS LTD PATENTS FACING OPPOSITIONS
Top patents of ACTELION PHARMACEUTICALS LTD facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3256125B1 | 26 Jan, 2022 | Dosing Regimen For A Selective S1P1 Receptor Agonist | Dec, 2035 | 2 | |
| EP3592391B1 | 21 Apr, 2021 | Pharmaceutical Composition Comprising Selexipag | Mar, 2038 | 1 |